Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (392)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
456
8.790
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
76
3.760
 Why?
Immunologic Factors
13
2025
237
2.570
 Why?
Neurology
10
2018
114
2.280
 Why?
Immunosuppressive Agents
10
2024
890
1.590
 Why?
Neuromyelitis Optica
4
2023
132
1.140
 Why?
Natalizumab
11
2021
40
0.950
 Why?
Recurrence
8
2025
1058
0.910
 Why?
Diagnostic Errors
2
2017
170
0.720
 Why?
Brain
16
2025
2669
0.710
 Why?
Internship and Residency
5
2011
1131
0.670
 Why?
Drug Substitution
2
2019
55
0.660
 Why?
Fingolimod Hydrochloride
5
2020
40
0.640
 Why?
Rituximab
4
2020
178
0.610
 Why?
Data Collection
4
2011
664
0.590
 Why?
Dementia, Vascular
3
2009
20
0.590
 Why?
Medication Adherence
2
2019
468
0.560
 Why?
Drug Monitoring
1
2019
219
0.560
 Why?
Early Medical Intervention
1
2017
57
0.530
 Why?
Early Diagnosis
2
2017
243
0.520
 Why?
Magnetic Resonance Imaging
24
2025
3566
0.510
 Why?
Glatiramer Acetate
6
2019
18
0.500
 Why?
Humans
87
2025
136783
0.500
 Why?
Calcinosis
2
2009
235
0.490
 Why?
Physicians
4
2016
897
0.480
 Why?
Postural Balance
3
2018
212
0.460
 Why?
Antibodies, Monoclonal, Humanized
8
2023
804
0.440
 Why?
Fatigue
3
2018
327
0.390
 Why?
Dimethyl Fumarate
3
2020
12
0.370
 Why?
Immunoglobulin G
4
2023
886
0.360
 Why?
Middle Aged
39
2025
33200
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.330
 Why?
Practice Guidelines as Topic
1
2018
1568
0.330
 Why?
Withholding Treatment
2
2021
76
0.320
 Why?
Adult
43
2025
37616
0.320
 Why?
Psychiatry
2
2009
181
0.300
 Why?
Cysts
1
2009
111
0.290
 Why?
Demyelinating Diseases
4
2019
85
0.290
 Why?
HIV Long Terminal Repeat
3
2001
11
0.290
 Why?
Education, Medical
1
2011
260
0.280
 Why?
Certification
1
2008
103
0.280
 Why?
Autoantibodies
3
2023
1500
0.270
 Why?
Lymphopenia
2
2020
61
0.270
 Why?
Female
49
2025
72840
0.270
 Why?
Education
2
2007
106
0.270
 Why?
Central Nervous System Cysts
1
2006
14
0.260
 Why?
Clinical Trials as Topic
3
2016
1043
0.260
 Why?
Male
40
2025
67361
0.260
 Why?
Cerebral Arteries
1
2006
59
0.250
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
51
0.250
 Why?
Single-Blind Method
3
2023
286
0.250
 Why?
Cerebrovascular Disorders
1
2006
96
0.250
 Why?
DNA, Viral
2
1998
362
0.240
 Why?
Ethics, Medical
2
2015
80
0.240
 Why?
Societies, Medical
4
2019
820
0.240
 Why?
HIV Seropositivity
2
1998
125
0.230
 Why?
Treatment Outcome
12
2023
10764
0.230
 Why?
Databases, Factual
3
2016
1347
0.220
 Why?
Drug Industry
2
2016
108
0.220
 Why?
Double-Blind Method
4
2023
1981
0.220
 Why?
Conflict of Interest
2
2016
127
0.210
 Why?
AIDS Dementia Complex
3
2001
51
0.210
 Why?
Microglia
2
2024
251
0.200
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
68
0.200
 Why?
Heart Aneurysm
1
2002
11
0.190
 Why?
Quality of Health Care
2
2017
627
0.190
 Why?
Heart Septal Defects, Atrial
1
2002
54
0.180
 Why?
B-Lymphocytes
5
2023
846
0.180
 Why?
Interferon beta-1a
2
2019
12
0.180
 Why?
Lymphoma
2
2005
206
0.180
 Why?
Neuroimaging
1
2023
263
0.180
 Why?
Mental Disorders
2
2007
1075
0.180
 Why?
Education, Medical, Continuing
2
2015
125
0.170
 Why?
Central Nervous System Neoplasms
2
2005
158
0.170
 Why?
Brain Neoplasms
4
2016
1241
0.170
 Why?
Agammaglobulinemia
1
2020
34
0.170
 Why?
Interferon-gamma
1
2023
790
0.160
 Why?
Serum Sickness
1
2019
6
0.160
 Why?
Indans
1
2019
11
0.160
 Why?
Neutropenia
1
2020
146
0.160
 Why?
Oxadiazoles
1
2019
33
0.160
 Why?
Disease Progression
4
2021
2750
0.160
 Why?
Referral and Consultation
1
2005
777
0.160
 Why?
Diagnosis, Differential
4
2023
1483
0.150
 Why?
Adjuvants, Immunologic
3
2015
226
0.140
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Salvage Therapy
1
2019
142
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
251
0.140
 Why?
Educational Measurement
3
2015
280
0.140
 Why?
Herpesvirus 8, Human
1
1998
63
0.140
 Why?
Physician-Patient Relations
2
2016
544
0.140
 Why?
Eye Movements
1
2018
67
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.140
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
615
0.140
 Why?
Central Nervous System
2
2005
258
0.140
 Why?
Sarcoma, Kaposi
1
1998
78
0.140
 Why?
Young Adult
7
2024
13126
0.140
 Why?
Patient Selection
2
2015
689
0.130
 Why?
Herpesvirus 4, Human
1
2018
167
0.130
 Why?
Nervous System Diseases
2
2024
265
0.130
 Why?
Herpesviridae Infections
1
1998
148
0.130
 Why?
Suicide, Assisted
1
1997
25
0.130
 Why?
Neurologists
1
2016
21
0.130
 Why?
Costs and Cost Analysis
1
2017
205
0.130
 Why?
Aged
9
2024
23729
0.130
 Why?
Cost-Benefit Analysis
2
2016
584
0.130
 Why?
Estriol
1
2015
8
0.130
 Why?
Dizziness
2
2018
83
0.120
 Why?
Retrospective Studies
10
2024
15564
0.120
 Why?
Verbal Learning
2
2013
65
0.120
 Why?
Corpus Callosum
2
2006
70
0.120
 Why?
Trust
1
2016
120
0.120
 Why?
T-Lymphocytes
1
2023
1998
0.110
 Why?
Follow-Up Studies
6
2020
5115
0.110
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
153
0.110
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
52
0.110
 Why?
Insurance, Health
1
2016
278
0.110
 Why?
Medication Reconciliation
1
2013
29
0.100
 Why?
CD40 Antigens
1
2014
89
0.100
 Why?
Exercise Therapy
1
2018
434
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
137
0.100
 Why?
Stroke
1
2002
1129
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Anti-Inflammatory Agents
2
2006
495
0.100
 Why?
Sensation Disorders
1
2012
34
0.100
 Why?
Memory Disorders
1
2013
164
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Population Surveillance
1
2016
470
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
83
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
37
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
16
0.090
 Why?
HIV-1
2
2001
857
0.090
 Why?
Optic Nerve
2
2005
64
0.090
 Why?
T-Lymphocyte Subsets
1
2014
425
0.090
 Why?
Glioma
1
2016
397
0.090
 Why?
United States
8
2024
14660
0.090
 Why?
Gadolinium
4
2018
82
0.090
 Why?
Academies and Institutes
1
2011
54
0.090
 Why?
Learning
1
2015
414
0.090
 Why?
Self-Assessment
1
2011
74
0.090
 Why?
Nerve Regeneration
1
2010
59
0.080
 Why?
Fatal Outcome
3
2006
304
0.080
 Why?
Leukocytosis
1
2010
31
0.080
 Why?
Diagnostic Tests, Routine
1
2011
109
0.080
 Why?
Quality of Life
3
2021
2868
0.080
 Why?
Antigens, CD19
3
2007
123
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
7
0.080
 Why?
Hemangioma, Cavernous
1
1989
15
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Biomarkers
3
2014
4158
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Exercise Test
1
2012
625
0.080
 Why?
Severity of Illness Index
3
2014
2831
0.080
 Why?
Disease Management
1
2013
623
0.080
 Why?
Guidelines as Topic
1
2011
276
0.080
 Why?
Spinal Cord
3
2023
369
0.080
 Why?
Physical Therapy Modalities
1
2011
308
0.070
 Why?
Neuroprotective Agents
1
2009
132
0.070
 Why?
Hospital-Physician Relations
1
2007
4
0.070
 Why?
Practice Patterns, Physicians'
1
2016
1294
0.070
 Why?
Immunoglobulin Variable Region
2
2004
80
0.070
 Why?
Workload
1
2009
161
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
14
0.070
 Why?
Neuropsychological Tests
2
2013
1054
0.070
 Why?
CD4-Positive T-Lymphocytes
1
1993
1092
0.070
 Why?
Headache Disorders
1
2006
18
0.070
 Why?
Antibodies, Monoclonal
2
2011
1428
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
47
0.070
 Why?
Medical Records
1
2007
172
0.060
 Why?
Methylprednisolone
1
2006
85
0.060
 Why?
Syndrome
2
2023
357
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
99
0.060
 Why?
International Classification of Diseases
1
2007
131
0.060
 Why?
Huntington Disease
1
2007
57
0.060
 Why?
Intracranial Hemorrhages
1
2006
84
0.060
 Why?
Antibody Formation
1
2007
298
0.060
 Why?
Contrast Media
3
2018
462
0.060
 Why?
Herpes Zoster
1
2010
316
0.060
 Why?
Adolescent
8
2024
21463
0.060
 Why?
Aquaporin 4
1
2006
94
0.060
 Why?
DNA Mutational Analysis
1
2006
400
0.060
 Why?
Canada
2
2019
420
0.060
 Why?
Fellowships and Scholarships
1
2009
306
0.060
 Why?
Health Care Surveys
1
2007
563
0.060
 Why?
Patient Compliance
1
2009
576
0.060
 Why?
Neurologic Examination
1
2005
113
0.060
 Why?
Cognition Disorders
1
2009
515
0.060
 Why?
Analysis of Variance
3
2015
1318
0.060
 Why?
Teaching
1
2007
226
0.060
 Why?
RNA, Messenger
1
1992
2831
0.060
 Why?
Surveys and Questionnaires
4
2016
5749
0.060
 Why?
Program Evaluation
1
2009
886
0.060
 Why?
Affect
1
2007
293
0.060
 Why?
Erythrocytes
1
2010
692
0.060
 Why?
Central Nervous System Diseases
1
2005
69
0.060
 Why?
Colorado
2
2024
4491
0.060
 Why?
Neutrophils
1
2010
1234
0.050
 Why?
Simvastatin
1
2004
61
0.050
 Why?
Ophthalmoplegia
1
2003
8
0.050
 Why?
Proteoglycans
1
2004
107
0.050
 Why?
Prevalence
2
2024
2712
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
39
0.050
 Why?
Faculty, Medical
1
2006
282
0.050
 Why?
B-Lymphocyte Subsets
1
2003
75
0.050
 Why?
Cyclophosphamide
1
2003
248
0.050
 Why?
Neurodegenerative Diseases
1
2024
136
0.050
 Why?
Radiography
1
2005
829
0.050
 Why?
Academic Medical Centers
1
2005
497
0.050
 Why?
Infusions, Intravenous
1
2023
408
0.050
 Why?
Anticoagulants
1
2006
658
0.050
 Why?
Patient Outcome Assessment
1
2023
130
0.050
 Why?
Lymphoma, B-Cell
2
2005
105
0.050
 Why?
Single-Cell Analysis
1
2024
310
0.050
 Why?
Students, Medical
1
2006
341
0.050
 Why?
Membrane Glycoproteins
1
2004
500
0.050
 Why?
Induced Pluripotent Stem Cells
1
2024
250
0.050
 Why?
Pain
1
2007
755
0.050
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.050
 Why?
Cross-Sectional Studies
1
2012
5417
0.040
 Why?
Dementia
1
2005
252
0.040
 Why?
Disability Evaluation
2
2014
289
0.040
 Why?
Molecular Sequence Data
3
2004
2903
0.040
 Why?
Schools, Medical
1
2002
146
0.040
 Why?
Time Factors
4
2018
6792
0.040
 Why?
Antibodies, Antinuclear
1
2001
71
0.040
 Why?
Peptides
3
2013
980
0.040
 Why?
Atrophy
1
2021
184
0.040
 Why?
Clinical Competence
1
2008
1093
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
155
0.040
 Why?
Consensus
1
2023
679
0.040
 Why?
Mobility Limitation
1
2020
61
0.040
 Why?
Venous Thrombosis
1
2002
186
0.040
 Why?
Child
5
2016
21968
0.040
 Why?
Interferon-beta
2
2011
92
0.040
 Why?
Lymphocyte Activation
1
2003
1150
0.040
 Why?
Antibodies, Viral
1
2023
622
0.040
 Why?
Maintenance Chemotherapy
1
2019
35
0.040
 Why?
Lipids
1
2023
665
0.040
 Why?
Induction Chemotherapy
1
2019
74
0.040
 Why?
Cerebral Infarction
1
1998
43
0.040
 Why?
Cell Separation
2
2014
318
0.040
 Why?
HIV Seronegativity
1
1998
28
0.040
 Why?
Transplantation, Autologous
1
2019
237
0.040
 Why?
Genes, myc
1
1998
48
0.040
 Why?
Base Sequence
2
2001
2180
0.040
 Why?
Astrocytoma
1
1998
128
0.030
 Why?
In Situ Hybridization
1
2018
315
0.030
 Why?
Gene Library
1
1997
117
0.030
 Why?
Risk Assessment
1
2006
3429
0.030
 Why?
Gene Rearrangement
1
1998
149
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
343
0.030
 Why?
Syndecan-1
2
2007
38
0.030
 Why?
Managed Care Programs
1
1997
129
0.030
 Why?
Breast Neoplasms
1
2008
2239
0.030
 Why?
Drug Administration Schedule
1
2018
783
0.030
 Why?
Viral Load
1
2018
460
0.030
 Why?
Morals
1
1997
80
0.030
 Why?
Risk Factors
3
2008
10331
0.030
 Why?
Flow Cytometry
2
2014
1181
0.030
 Why?
Mutation
1
2006
3953
0.030
 Why?
Survival Analysis
1
2018
1319
0.030
 Why?
Polymerase Chain Reaction
1
1998
1059
0.030
 Why?
Sequence Analysis, DNA
1
1997
811
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1323
0.030
 Why?
Child, Preschool
3
2016
11069
0.030
 Why?
Patient Care Team
1
2019
627
0.030
 Why?
Incidence
1
2020
2788
0.030
 Why?
Congresses as Topic
1
2015
233
0.030
 Why?
Propylene Glycols
1
2013
28
0.030
 Why?
Ocular Physiological Phenomena
1
1992
9
0.030
 Why?
HLA-DR Antigens
1
2014
228
0.030
 Why?
Sphingosine
1
2013
46
0.020
 Why?
beta-Galactosidase
1
1992
77
0.020
 Why?
Quality-Adjusted Life Years
1
2013
112
0.020
 Why?
Markov Chains
1
2013
122
0.020
 Why?
Drug Therapy, Combination
1
2015
1059
0.020
 Why?
Mice, Inbred DBA
1
1992
200
0.020
 Why?
Leukocyte Count
1
1993
330
0.020
 Why?
Haplotypes
1
2014
490
0.020
 Why?
Organ Specificity
1
1992
304
0.020
 Why?
Comparative Effectiveness Research
1
2013
150
0.020
 Why?
Mental Recall
1
2013
201
0.020
 Why?
Reference Values
1
2013
817
0.020
 Why?
Ki-67 Antigen
1
2012
111
0.020
 Why?
CD3 Complex
1
2012
106
0.020
 Why?
Thymus Gland
1
1992
313
0.020
 Why?
Intestine, Small
1
1992
154
0.020
 Why?
Mice
2
2023
17731
0.020
 Why?
Mitoxantrone
1
2011
14
0.020
 Why?
Animals
3
2023
36768
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Patient Participation
1
2015
416
0.020
 Why?
Depression
2
2011
1402
0.020
 Why?
Clinical Laboratory Techniques
1
2011
98
0.020
 Why?
Recombinant Fusion Proteins
1
1992
663
0.020
 Why?
Amino Acid Sequence
2
2004
2145
0.020
 Why?
Physical Endurance
1
2011
277
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1455
0.020
 Why?
Acyclovir
1
2010
99
0.020
 Why?
Spinal Cord Neoplasms
1
1989
37
0.020
 Why?
Aged, 80 and over
2
2016
7569
0.020
 Why?
Cell Count
1
2010
321
0.020
 Why?
History, 19th Century
1
2009
60
0.020
 Why?
Respiratory Function Tests
1
2011
596
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
57
0.020
 Why?
Injections
1
2009
181
0.020
 Why?
Pilot Projects
2
2004
1697
0.020
 Why?
History, 21st Century
1
2009
211
0.020
 Why?
Autoimmunity
1
2014
908
0.020
 Why?
Electrocardiography
1
2011
628
0.020
 Why?
History, 20th Century
1
2009
323
0.020
 Why?
Gene Expression
1
1992
1499
0.020
 Why?
Age of Onset
1
2009
518
0.020
 Why?
Mice, Transgenic
1
1992
2162
0.020
 Why?
Health
1
2007
84
0.020
 Why?
Memory
1
2009
255
0.020
 Why?
Association Learning
1
2007
60
0.020
 Why?
Walking
1
2011
524
0.020
 Why?
Herpesvirus 3, Human
1
2010
332
0.020
 Why?
Cerebral Ventricles
1
2006
52
0.020
 Why?
Prognosis
2
2006
4018
0.020
 Why?
Motor Skills
1
2007
98
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
913
0.020
 Why?
Hypothalamus
1
2006
153
0.020
 Why?
Genetics
1
2005
27
0.010
 Why?
Phenotype
1
2014
3199
0.010
 Why?
Models, Theoretical
1
2009
572
0.010
 Why?
Immunologic Memory
1
2007
369
0.010
 Why?
Neurosciences
1
2005
25
0.010
 Why?
Hospitalization
1
2015
2195
0.010
 Why?
Social Support
1
2009
615
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Clinical Protocols
1
2006
268
0.010
 Why?
Internet
1
2009
648
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
267
0.010
 Why?
Anisotropy
1
2004
79
0.010
 Why?
Immune System
1
2005
177
0.010
 Why?
Plasma Cells
1
2004
71
0.010
 Why?
Antiviral Agents
1
2010
736
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Videotape Recording
1
2003
35
0.010
 Why?
Infrared Rays
1
2003
25
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Saccades
1
2003
40
0.010
 Why?
Antilymphocyte Serum
1
2003
64
0.010
 Why?
Oligoclonal Bands
1
2003
20
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
124
0.010
 Why?
Antigens, CD34
1
2003
88
0.010
 Why?
Clone Cells
1
2003
266
0.010
 Why?
Whole-Body Irradiation
1
2003
78
0.010
 Why?
Astrocytes
1
2005
210
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
130
0.010
 Why?
Immunoglobulins
1
2003
171
0.010
 Why?
Observer Variation
1
2003
345
0.010
 Why?
Feasibility Studies
1
2006
947
0.010
 Why?
Mice, Inbred C57BL
1
1992
5744
0.010
 Why?
Administration, Oral
1
2004
808
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2677
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
8
0.010
 Why?
Longitudinal Studies
1
2009
2847
0.010
 Why?
Sex Characteristics
1
2007
763
0.010
 Why?
Age Factors
1
2009
3290
0.010
 Why?
Consensus Sequence
1
2001
73
0.010
 Why?
Cytomegalovirus Infections
1
2003
191
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
973
0.010
 Why?
Biopsy
1
2005
1126
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
20
0.010
 Why?
Urinary Tract Infections
1
2003
168
0.010
 Why?
Infant
1
2015
9442
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
59
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
92
0.010
 Why?
Cohort Studies
1
2011
5718
0.010
 Why?
Predictive Value of Tests
1
2006
2030
0.010
 Why?
Acute Disease
1
2003
1006
0.010
 Why?
Research
1
2003
445
0.010
 Why?
Combined Modality Therapy
1
2003
1235
0.010
 Why?
Lung
1
1992
4065
0.010
 Why?
Arachnoid
1
1998
12
0.010
 Why?
Sensitivity and Specificity
1
2003
1942
0.010
 Why?
Survival Rate
1
2003
1969
0.010
 Why?
Monocytes
1
2001
561
0.010
 Why?
Virus Replication
1
2001
479
0.010
 Why?
Models, Biological
1
2005
1769
0.010
 Why?
Binding Sites
1
2001
1308
0.010
 Why?
Case-Control Studies
1
2004
3537
0.010
 Why?
Aging
1
2007
1861
0.010
 Why?
Reproducibility of Results
1
2003
3272
0.010
 Why?
Transcription, Genetic
1
2001
1453
0.010
 Why?
DNA-Binding Proteins
1
2001
1500
0.010
 Why?
Cells, Cultured
1
2001
4194
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (392) concept(s)
_
Co-Authors Expand Description
See all (36) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)